Nonprofit · EIN 99-0991065
DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC
Tax-exempt · NEW YORK, NY 10017
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $629,357 | $97,425 | $531,932 | $538,884 | $0 | $538,884 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $615,339
- Program service revenue
- $0
- Investment income
- $14,018
- Net gain from sales of assets
- $17
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Fundraising (functional)
- $97,425
Balance sheet and other
- Total assets, start of year
- $0
- Total assets, end of year
- $538,884
- Total liabilities, end of year
- $0
- Net assets, end of year
- $538,884
- Publicly traded securities
- $531,849
- Net assets without donor restrictions
- $538,884
- Gross receipts
- $2,229,833
- Employees
- 0
- Volunteers
- 0
- Year formed
- 2024
- State of legal domicile
- NY
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| MORRIS OFFIT | DIRECTOR Trustee or director | 2 | $0 |
| NED OFFIT | PRESIDENT Trustee or director, Officer | 2 | $0 |
| VINCENT RELLA | SECRETARY/TREASURER Trustee or director, Officer | 2 | $0 |
Address and contacts
- Address (IRS master file)
- 485 LEXINGTON AVE FL 24, NEW YORK, NY 10017-2640
- In care of
- % OFFIT CAPITAL ADVISORS LLC
- Principal officer (990 for 2024)
- VINCENT RELLA, 485 LEXINGTON AVENUE, NEW YORK, NY 10017
- Signed the 990
- VINCENT RELLA, CHIEF FINANCIAL OFFICER
- Phone
- (212) 588-3264
- Website
- WWW.DANIELWOFFITFUND.ORG
- Return prepared by
- EISNER ADVISORY GROUP LLC
Mission
THE DANIEL W. OFFIT FUND TO FIGHT GLIOBLASTOMA IS DEDICATED TO ADVANCING GLIOBLASTOMA RESEARCH AND THERAPIES.
Program accomplishments
- THE DANIEL W. OFFIT FUND TO FIGHT GLIOBLASTOMA, INC. (THE ORGANIZATION) PLANS TO FUNDRAISE TO FUND RESEARCH AND THERAPIES FOR CANCER, INCLUDING IN PARTICULAR GLIOBLASTOMA. THE GLIOBLASTOMA MULTIFORME (GBM) IS THE MOST COMMON AND DEADLIEST FORM OF ADULT BRAIN CANCER. TO DATE THERE HAS BEEN LITTLE PROGRESS MADE IN IDENTIFYING A CURE FOR THIS DISEASE, WITH THE AVERAGE LIFE EXPECTANCY AFTER DIAGNOSIS SADLY BEING AROUND 14 MONTHS. (CONTINUED SCHED O)(CONTINUED FROM PAGE 2, PART III, 4A) THE ORGANIZATION INTENDS TO FUNDRAISE FROM THE PUBLIC, INCLUDING THROUGH FUNDRAISING EVENTS, AND ALL OF THE FUNDS RAISED BY THE ORGANIZATION WILL BE USED TO FUND AND ADVANCE FURTHER RESEARCH AND THERAPIES FOR CANCER, INCLUDING IN PARTICULAR GBM.THE ORGANIZATION INTENDS TO HAVE A SCIENTIFIC ADVISORY BOARD (SAB), WHICH WILL BE COMPOSED OF EXPERT MEDICAL AND RESEARCH PROFESSIONALS, TO ADVISE THE ORGANIZATION ON THE PROJECTS THAT HAVE THE MOST VIABLE PATH TO A CURE FOR GBM. THE ORGANIZATION WILL USE THE FEEDBACK OF ITS SAB TO DETERMINE THE MOST IMPORTANT RESEARCH PRIORITIES AND TO SOLICIT AND FUND RESEARCH PROPOSALS AIMED AT ADDRESSING THESE PRIORITIES. THE ORGANIZATION WILL ENSURE THAT ANY GRANTS IT MAKES ARE SELECTED AND DISTRIBUTED THROUGH AN OPEN AND DISINTERESTED PROCESS AND THROUGH EXISTING ACADEMIC AND PROFESSIONAL INFRASTRUCTURES.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | Check at the IRS |
IRS record
- EIN
- 99-0991065
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2024
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H30)
- Assets (IRS master file)
- $538,884
- Income (IRS master file)
- $2,229,833
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $629,357 | $97,425 | $538,884 | XML |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 99-0991065).
Questions about DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC
- What is the EIN of DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC?
- The employer identification number (EIN) of DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC is 99-0991065.
- Is DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2024.
- Are donations to DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC?
- The 990 for the year ended December 31, 2024 names VINCENT RELLA.
- Who are the officers and directors of DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC?
- The 990 for the year ended December 31, 2024 lists 3 people; 0 received compensation from the organization.
- How much revenue does DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $629,357, expenses of $97,425 and total assets of $538,884 at year end.
Other nonprofits in NEW YORK
- MICHAEL J FOX FOUNDATION FOR PARKINSONS RESEARCH EIN 13-4141945 · last filed 990 for 2025
- PUBLIC HEALTH SOLUTIONS EIN 13-5669201 · last filed 990 for 2025
- PARKINSONS FOUNDATION INC EIN 13-1866796 · last filed 990 for 2025
- LICR FUND INC EIN 13-3573053 · last filed 990 for 2024
- CARDIOVASCULAR RESEARCH FOUNDATION EIN 52-1752653 · last filed 990 for 2024
- GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC EIN 13-4128413 · last filed 990 for 2024
- INTERNATIONAL BRAIN RESEARCH ORGANIZATION EIN 88-4372025 · last filed 990 for 2024
- CANCER RESEARCH INSTITUTE INC EIN 13-1837442 · last filed 990 for 2025